Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Restructuring Costs: 2016-2017

Historic Restructuring Costs for Fortress Biotech (FBIO) over the last 2 years, with Dec 2017 value amounting to $8.8 million.

  • Fortress Biotech's Restructuring Costs fell 52.19% to $1.7 million in Q3 2018 from the same period last year, while for Sep 2018 it was $7.3 million, marking a year-over-year decrease of 3.91%. This contributed to the annual value of $8.8 million for FY2017, which is 2696.19% up from last year.
  • Latest data reveals that Fortress Biotech reported Restructuring Costs of $8.8 million as of FY2017, which was up 2,696.19% from $315,000 recorded in FY2016.
  • Over the past 5 years, Fortress Biotech's Restructuring Costs peaked at $8.8 million during FY2017, and registered a low of $315,000 during FY2016.
  • In the last 2 years, Fortress Biotech's Restructuring Costs had a median value of $4.6 million in 2016 and averaged $4.6 million.
  • Data for Fortress Biotech's Restructuring Costs shows a peak YoY surged of 2,696.19% (in 2017) over the last 5 years.
  • Over the past 2 years, Fortress Biotech's Restructuring Costs (Yearly) stood at $315,000 in 2016, then soared by 2,696.19% to $8.8 million in 2017.